FINWIRES · TerminalLIVE
FINWIRES

Tiziana Life Sciences Completes Patient Enrollment for Phase 2a Multiple Sclerosis Trial

By

Tiziana Life Sciences (TLSA) has completed patient enrollment for the phase 2a clinical trial evaluating intranasal foralumab in patients with non-active secondary progressive multiple sclerosis.

The trial enrolled 48 patients in the US who will receive one of two doses of intranasal foralumab or placebo over a 12-week period, to be followed by a six-month open label extension phase, the company said.

Topline data from the trial is expected in late Q3, Tiziana added.

Price: $1.73, Change: $+0.12, Percent Change: +7.45%

Related Articles

Wire

Update: EnerSys Fiscal Q4 Adjusted Earnings, Revenue Rise; Shares Gain After Hours

(Updates with dividend in the penultimate paragraph and stock movement in the last.)EnerSys (ENS) reported fiscal Q4 adjusted earnings late Wednesday of $3.19 per diluted share, up from $2.97 a year earlier.Analysts polled by FactSet expected $2.99.Revenue in the three months ended March 31 rose to $988 million from $974.8 million a year earlier.Analysts surveyed by FactSet expected $973.8 million.EnerSys expects Q1 revenue of $915 million to $955 million.Analysts polled by FactSet expect $914.6 million.The company maintained its quarterly dividend at $0.2625 a share, payable July 2 to stockholders of record June 19.EnerSys shares rose 6.7% in after-hours trading.

$ENS
Wire

E.l.f. Beauty Fiscal Q4 Adjusted Earnings Fall, Revenue Rises; Issues Fiscal 2027 Guidance

E.l.f. Beauty (ELF) reported fiscal Q4 adjusted net income late Wednesday of $0.32 per diluted share, down from $0.78 a year earlier.Analysts polled by FactSet expected $0.29.Revenue for the quarter ended March 31 rose to $449.3 million from $332.6 million a year earlier.Analysts polled by FactSet expected $423.1 million.For fiscal 2027, the company expects adjusted EPS of $3.27 to $3.32 on revenue of $1.84 billion to $1.87 billion. Analysts expect $3.61 and $1.86 billion, respectively.Shares of the company rose 6% in after-hours activity.

$ELF
Wire

GUIDANCE: (INTU) Intuit Expects Fiscal 2026 Revenue Range $21.341B-$21.374B, vs. FactSet Est of $21.24B

GUIDANCE: (INTU) Intuit Expects Fiscal 2026 Revenue Range $21.341B-$21.374B, vs. FactSet Est of $21.24B

$INTU